NCT05887947View on ClinicalTrials.gov

Impact of E-cigarette Nicotine Concentration on Compensation

NACompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

February 20, 2023

Primary Completion Date

May 3, 2024

Study Completion Date

June 10, 2024

Conditions
Smoking Cessation
Interventions
DEVICE

Electronic Cigarette with 5% Nicotine Concentration

Electronic cigarette in 5% nicotine concentration (Vuse Alto), provided for free.

DEVICE

Electronic Cigarette with 1.8% Nicotine Concentration

Electronic cigarette in 1.8% nicotine concentration (Vuse Alto), provided for free.

Trial Locations (1)

66160

University of Kansas Medical Center, Kansas City

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

University of Kansas Medical Center

OTHER